European Heart Journal
Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial
Randomised trial in peopleSemaglutide
Papers by Peter E. Weeke
3 results
- ADA Scientific Sessions 2026 Abstract
Serum Proteomics Suggest Novel Mechanisms of Action of Semaglutide in Reducing the Risk of MACE in the SELECT Trial
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Exploring Semaglutide's Effect on the ASCVD-Related Proteomic Signature and Their Prediction of MACE in SELECT
Trial in peopleInterventions